BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Oct 18, 2004
Insider Transaction Report
Form 4
ROSENOW EDWARD C III
Director
Transactions
- Exercise/Conversion
Common Stock
2004-10-15$2.85/sh+7,500$21,375→ 20,039 total - Exercise/Conversion
Stock Option (right to buy)
2004-10-15$2.85/sh−7,500$21,375→ 0 totalExercise: $2.85From: 2000-10-27Exp: 2004-10-27→ Common Stock (7,500 underlying)